US OptionsDetailed Quotes
AUR241115C4500
- 0.51
- -0.46-47.42%
15min DelayClose Nov 15 16:00 ET
0.55High0.45Low
0.55Open0.97Pre Close4 Volume156 Open Interest4.50Strike Price202.00Turnover0.00%IV0.40%PremiumNov 15, 2024Expiry Date0.49Intrinsic Value100Multiplier0DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.51Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Aurora Innovation Stock Discussion
Once this sell-off is done, time to jump back in.
The delay in launch (as stated in earnings call) was due to factors outside their control. Paccar supply issues prevented the timeline for regulations and testing being met.
To see why this isn't a bad thing, refer to "contra R&D expense"
Some assistance for the unfamiliar:
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
as a high reward with decreasing risks play, for short term trades, and, if they show that they can scale, a longterm hold.
It is part of my speculation basket that includes companies like $AST SpaceMobile (ASTS.US)$
and $Aurora Innovation (AUR.US)$
all of which I trade in shorterm options, trade and invest in longer dated contracts and warrants, and invest in shares, LEAPS calls and synthetic longs.
I’ve traded out of December AUR cal...
loading...
$Concentration$
$Concentration$
$Speculation$
Obviously not a long time frame. Handily beats depending on risk definition. This is buy and hold high risk but less and kess risky to my estimates.
No comment yet